MEK INHIBITORS

Researchers discover major cause of inflammatory bowel disease

​An autoimmune disease, such as IBD, which encompasses Crohn's disease and ulcerative colitis, presently affects approximately 5% of the world's population and one in every 10 people in the United Kingdom1. These diseases are also becoming increasingly widespread, with over half a million individuals in the UK living with IBD by 2022, nearly double the previous prediction of 300,000.